Spagnolo, C.C.; Giuffrida, G.; Cannavò, S.; Franchina, T.; Silvestris, N.; Ruggeri, R.M.; Santarpia, M.
Management of Endocrine and Metabolic Toxicities of Immune-Checkpoint Inhibitors: From Clinical Studies to a Real-Life Scenario. Cancers 2023, 15, 246.
https://doi.org/10.3390/cancers15010246
AMA Style
Spagnolo CC, Giuffrida G, Cannavò S, Franchina T, Silvestris N, Ruggeri RM, Santarpia M.
Management of Endocrine and Metabolic Toxicities of Immune-Checkpoint Inhibitors: From Clinical Studies to a Real-Life Scenario. Cancers. 2023; 15(1):246.
https://doi.org/10.3390/cancers15010246
Chicago/Turabian Style
Spagnolo, Calogera Claudia, Giuseppe Giuffrida, Salvatore Cannavò, Tindara Franchina, Nicola Silvestris, Rosaria Maddalena Ruggeri, and Mariacarmela Santarpia.
2023. "Management of Endocrine and Metabolic Toxicities of Immune-Checkpoint Inhibitors: From Clinical Studies to a Real-Life Scenario" Cancers 15, no. 1: 246.
https://doi.org/10.3390/cancers15010246
APA Style
Spagnolo, C. C., Giuffrida, G., Cannavò, S., Franchina, T., Silvestris, N., Ruggeri, R. M., & Santarpia, M.
(2023). Management of Endocrine and Metabolic Toxicities of Immune-Checkpoint Inhibitors: From Clinical Studies to a Real-Life Scenario. Cancers, 15(1), 246.
https://doi.org/10.3390/cancers15010246